NAVNETEDUL : Increasing momentum
If sustain the current momentum - we can see a strong upside. Add to watchlist.
In the last 2 weeks - we see a slow and steady growth from 95 to 111. Expected to test 121 and beyond.
2022-07-18: Close is above SMA 20 on Daily/Weekly/Monthly time frames. M trend is +ve & W trend Change to +ve today. Price Crossed Upside 50-SMA on Monthly time frame. D13>34>55 & Close crossed D13 Up W Close Crossed W13 Upside. Also Normal NR7 - Breakout
2022-07-19: Cross WK Piv Upside & W SMA 13>34>55 & Close crossed W13 Upside
2022-07-20: SMA 30 crossed SMA 100 Upside. Possible Long. Also Crossing 4 week High
2022-07-21: Possible strong upside movement
2022-07-25: Spike in ADX. ADX >26 DI+ > 32 (Don't miss this)
2022-07-26: Increase in ADX. Also Normal NR7 - Inside Candle
2022-07-27: Normal NR7 - Breakout
2022-07-28: ADX>31, DI+> 33.0, Doji Star
2022-07-29: ADX>33, DI+ > 34, Crossing 4 week High
MY analysis may not be correct ... otherwise, I should be rich enough to do something else.
Please spend time on your own research before taking a call.
In the last 2 weeks - we see a slow and steady growth from 95 to 111. Expected to test 121 and beyond.
2022-07-18: Close is above SMA 20 on Daily/Weekly/Monthly time frames. M trend is +ve & W trend Change to +ve today. Price Crossed Upside 50-SMA on Monthly time frame. D13>34>55 & Close crossed D13 Up W Close Crossed W13 Upside. Also Normal NR7 - Breakout
2022-07-19: Cross WK Piv Upside & W SMA 13>34>55 & Close crossed W13 Upside
2022-07-20: SMA 30 crossed SMA 100 Upside. Possible Long. Also Crossing 4 week High
2022-07-21: Possible strong upside movement
2022-07-25: Spike in ADX. ADX >26 DI+ > 32 (Don't miss this)
2022-07-26: Increase in ADX. Also Normal NR7 - Inside Candle
2022-07-27: Normal NR7 - Breakout
2022-07-28: ADX>31, DI+> 33.0, Doji Star
2022-07-29: ADX>33, DI+ > 34, Crossing 4 week High
MY analysis may not be correct ... otherwise, I should be rich enough to do something else.
Please spend time on your own research before taking a call.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.